| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $419M | — | $330M | — | 26.9% |
| Op. Income | $33M | — | $7M | — | 361.0% |
| Gross Margin | 74.1% | — | 75.0% | — | -1.0pp |
| Net Margin | 8.4% | — | -8.8% | — | 17.2pp |
| EPS (Diluted) | $0.15 | — | $-0.16 | — | 193.8% |
| Free Cash Flow | $82M | — | $86M | — | -5.0% |
| Item | Amount |
|---|---|
| REVENUE | $419M |
| Cost of Revenue | $109M |
| GROSS PROFIT | $311M |
| R&D Expenses | $53M |
| Selling & Marketing | $144M |
| General & Administrative | $81M |
| SG&A Expenses | $225M |
| Other Expenses | $0 |
| Operating Expenses | $278M |
| Cost & Expenses | $386M |
| OPERATING INCOME | $33M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $7M |
| INCOME BEFORE TAX | $41M |
| Income Tax Expense | $5M |
| Net Income from Continuing Ops | $35M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $35M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $35M |
| D&A | $6M |
| EBIT | $0 |
| EBITDA | $6M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $419M |
| Cost of Revenue | $109M |
| GROSS PROFIT | $311M |
| R&D Expenses | $53M |
| Selling & Marketing | $144M |
| General & Administrative | $81M |
| SG&A Expenses | $225M |
| Other Expenses | $0 |
| Operating Expenses | $278M |
| Cost & Expenses | $386M |
| OPERATING INCOME | $33M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $7M |
| INCOME BEFORE TAX | $41M |
| Income Tax Expense | $5M |
| Net Income from Continuing Ops | $35M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $35M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $35M |
| D&A | $6M |
| EBIT | $0 |
| EBITDA | $6M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $35M |
| Depreciation & Amortization | $6M |
| Stock-Based Compensation | $39M |
| Deferred Income Tax | -$2M |
| Other Non-Cash Items | $7M |
| Change in Working Capital | $0 |
| OPERATING CASH FLOW | $85M |
| Capital Expenditure | -$4M |
| Acquisitions (Net) | -$15M |
| Purchases of Investments | -$167.0K |
| Sales/Maturities of Investments | $167.0K |
| Other Investing Activities | -$2M |
| NET CASH FROM INVESTING | -$20M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$50M |
| Common Dividends Paid | $0 |
| Other Financing Activities | $124M |
| NET CASH FROM FINANCING | $124M |
| FREE CASH FLOW | $82M |
| Net Change in Cash | $190M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $481M |
| Short-Term Investments | $0 |
| Net Receivables | $125M |
| Inventory | $0 |
| Other Current Assets | $20M |
| TOTAL CURRENT ASSETS | $625M |
| PP&E (Net) | $23M |
| Goodwill | $38M |
| Intangible Assets | $12M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $91M |
| TOTAL NON-CURRENT ASSETS | $164M |
| TOTAL ASSETS | $789M |
| Account Payables | $4M |
| Short-Term Debt | $0 |
| Deferred Revenue | $186M |
| Other Current Liabilities | $84M |
| TOTAL CURRENT LIABILITIES | $274M |
| Long-Term Debt | $10M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $27M |
| TOTAL NON-CURRENT LIABILITIES | $37M |
| TOTAL LIABILITIES | $310M |
| Common Stock | $22.0K |
| Additional Paid-In Capital | $0 |
| Retained Earnings | -$510M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $8M |
| Other Equity | $980M |
| TOTAL STOCKHOLDERS' EQUITY | $479M |
| Minority Interest | $0 |
| TOTAL EQUITY | $479M |
| TOTAL LIABILITIES & EQUITY | $789M |
| Total Debt | $10M |
| Net Debt | -$471M |
